DoctorsProofNPPES directory · verify at state boards

Pulmonary Disease in Huntsville, AL

16 verified pulmonary disease doctors in Huntsville.

Pulmonologists diagnose and treat diseases of the lungs and respiratory system, such as asthma, COPD, and sleep apnea.

NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.

Verify a license at the Alabama Board of Medical Examiners

Dr. Devi Misra, MD

Pulmonary Disease

20 yrs NPPES
NPI 1174597942
400 WHITESPORT DR SW, SUITE 103, Huntsville, AL 35801(256) 880-0455
NPPES public registry
CMS Open Payments· No payments in 2023

Industry Payments

No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.

Dr. William Mccrory, MD

Pulmonary Disease

20 yrs NPPES
NPI 1023070323
725 MADISON ST SE, Huntsville, AL 35801(256) 265-5864
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $645.65 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$645.65

Total received

29

Transactions

9

Paying companies

Top paying companies

GlaxoSmithKline, LLC.$214.71
Regeneron Healthcare Solutions, Inc.$204.23
Insmed, Inc.$79.18
AstraZeneca Pharmaceuticals LP$40.39
United Therapeutics Corporation$25.65
Grifols USA, LLC$24.21

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 76th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to William Mccrory do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Richard Sneeringer, MD

Pulmonary Disease

20 yrs NPPES
NPI 1598711749
725 MADISON ST SE, Huntsville, AL 35801(256) 265-5864
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $2,457 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$2,457

Total received

121

Transactions

24

Paying companies

Top paying companies

AstraZeneca Pharmaceuticals LP$517.67
GlaxoSmithKline, LLC.$474.90
Regeneron Healthcare Solutions, Inc.$335.37
Boehringer Ingelheim Pharmaceuticals, Inc.$156.56
Insmed, Inc.$106.84
Takeda Pharmaceuticals U.S.A., Inc.$103.21

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 88th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Richard Sneeringer do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Murthy Vuppala, MD

Pulmonary Disease

20 yrs NPPES
NPI 1093762346
725 MADISON ST SE, Huntsville, AL 35801(256) 883-2112
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $2,234 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$2,234

Total received

110

Transactions

19

Paying companies

Top paying companies

AstraZeneca Pharmaceuticals LP$523.69
GlaxoSmithKline, LLC.$499.41
Regeneron Healthcare Solutions, Inc.$251.17
Boehringer Ingelheim Pharmaceuticals, Inc.$152.26
Mallinckrodt Hospital Products Inc.$116.72
Insmed, Inc.$107.67

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 87th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Murthy Vuppala do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Jason Smith, MD

Pulmonary Disease

20 yrs NPPES
NPI 1053419341
1104 MONROE ST SW, Huntsville, AL 35801(256) 265-5864
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $1,539 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$1,539

Total received

78

Transactions

17

Paying companies

Top paying companies

GlaxoSmithKline, LLC.$427.33
AstraZeneca Pharmaceuticals LP$187.10
Harmony Biosciences LLC$140.02
NOVARTIS PHARMACEUTICALS CORPORATION$113.93
Insmed, Inc.$112.19
Takeda Pharmaceuticals U.S.A., Inc.$94.58

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 83th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Jason Smith do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Misbahuddin Siddiqui, MD

Pulmonary Disease

20 yrs NPPES
NPI 1114028271
725 MADISON STREET, Huntsville, AL 35801(256) 883-2110
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $2,004 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$2,004

Total received

102

Transactions

19

Paying companies

Top paying companies

GlaxoSmithKline, LLC.$604.63
AstraZeneca Pharmaceuticals LP$474.76
Regeneron Healthcare Solutions, Inc.$333.77
Takeda Pharmaceuticals U.S.A., Inc.$96.83
Genzyme Corporation$65.96
NOVARTIS PHARMACEUTICALS CORPORATION$57.83

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 86th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Misbahuddin Siddiqui do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Robert Serio, MD

Pulmonary Disease

20 yrs NPPES
NPI 1265518716
1104 MONROE ST SW, Huntsville, AL 35801(256) 265-5864
NPPES public registry
CMS Open Payments· $80.35 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$80.35

Total received

3

Transactions

3

Paying companies

Top paying companies

Inspire Medical Systems, Inc.$45.77
NOVARTIS PHARMACEUTICALS CORPORATION$18.34
Insmed, Inc.$16.24

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 56th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Robert Serio do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Luther Corley, MD

Pulmonary Disease

20 yrs NPPES
NPI 1790861292
1104 MONROE ST SW, Huntsville, AL 35801(256) 265-5864
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $30,952 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$30,952

Total received

115

Transactions

17

Paying companies

Top paying companies

Genzyme Corporation$27,755
Regeneron Healthcare Solutions, Inc.$1,751
GlaxoSmithKline, LLC.$419.28
AstraZeneca Pharmaceuticals LP$174.60
Pharming Healthcare, Inc.$163.32
NOVARTIS PHARMACEUTICALS CORPORATION$113.93

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total is higher than 95% of that group — among the highest recipients.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Luther Corley do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Milton Legrand, MD

Pulmonary Disease

20 yrs NPPES
NPI 1639240963
600 SAINT CLAIR AVE SW, BUILDING 8 SUITE 22, Huntsville, AL 35801(256) 533-6003
NPPES public registry
CMS Open Payments· No payments in 2023

Industry Payments

No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.

Dr. Melinda Thompson, MD

Pulmonary Disease

20 yrs NPPES
NPI 1255497392
406 GOVERNORS DR SW, Huntsville, AL 35801(256) 551-0003
NPPES public registry
CMS Open Payments· No payments in 2023

Industry Payments

No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.

Dr. Roshen Mathew, MD

Pulmonary Disease

16 yrs NPPES
NPI 1447563812
725 MADISON ST SE, Huntsville, AL 35801(256) 883-2112
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $2,617 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$2,617

Total received

11

Transactions

2

Paying companies

Top paying companies

Noah Medical Corporation$2,576
Pulmonx Corporation$41.64

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 88th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Roshen Mathew do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Tarun Kukkadapu, MD

Pulmonary Disease

13 yrs NPPES
NPI 1003256900
1104 MONROE ST SW, Huntsville, AL 35801(256) 265-5864
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $118.55 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$118.55

Total received

1

Transactions

1

Paying companies

Top paying companies

United Therapeutics Corporation$118.55

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 59th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Tarun Kukkadapu do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Muhammad Shafi, MD

Pulmonary Disease

13 yrs NPPES
NPI 1407298029
1104 MONROE ST SW, Huntsville, AL 35801(256) 265-5864
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $1,161 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$1,161

Total received

61

Transactions

16

Paying companies

Top paying companies

GlaxoSmithKline, LLC.$248.01
Takeda Pharmaceuticals U.S.A., Inc.$114.11
NOVARTIS PHARMACEUTICALS CORPORATION$113.93
Boehringer Ingelheim Pharmaceuticals, Inc.$113.27
Insmed, Inc.$95.95
AstraZeneca Pharmaceuticals LP$78.94

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 81th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Muhammad Shafi do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Diwas Shahi, MD

Pulmonary Disease

11 yrs NPPES
NPI 1053791467
420 LOWELL DRIVE 5TH FLOOR, Huntsville, AL 35801(256) 265-5864
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $1,213 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$1,213

Total received

62

Transactions

17

Paying companies

Top paying companies

GlaxoSmithKline, LLC.$362.35
Jazz Pharmaceuticals Inc.$123.06
Boehringer Ingelheim Pharmaceuticals, Inc.$113.98
Grifols USA, LLC$93.97
Takeda Pharmaceuticals U.S.A., Inc.$87.37
AstraZeneca Pharmaceuticals LP$77.61

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 81th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Diwas Shahi do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Saketh Palasamudram Shekar, MD

Pulmonary Disease

11 yrs NPPES
NPI 1154795052
725 MADISON ST SE, Huntsville, AL 35801(256) 265-5864
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $2,398 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$2,398

Total received

89

Transactions

15

Paying companies

Top paying companies

Medtronic, Inc.$802.49
GlaxoSmithKline, LLC.$462.70
AstraZeneca Pharmaceuticals LP$434.87
Regeneron Healthcare Solutions, Inc.$287.06
Insmed, Inc.$80.28
Takeda Pharmaceuticals U.S.A., Inc.$57.94

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 87th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Saketh Palasamudram Shekar do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Derek Wells, MD

Pulmonary Disease

10 yrs NPPES
NPI 1407209471
725 MADISON ST SE, Huntsville, AL 35801(256) 265-5864
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $1,659 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$1,659

Total received

76

Transactions

12

Paying companies

Top paying companies

GlaxoSmithKline, LLC.$536.64
AstraZeneca Pharmaceuticals LP$471.47
Regeneron Healthcare Solutions, Inc.$202.35
Boehringer Ingelheim Pharmaceuticals, Inc.$175.55
Takeda Pharmaceuticals U.S.A., Inc.$60.04
Insmed, Inc.$52.09

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 84th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Derek Wells do not imply any wrongdoing. Many are meals, education, or research support.

Pulmonary Disease in Huntsville, AL — Verified | DoctorsProof | DoctorsProof